UAE-based pharmaceutical firm Gulf Pharmaceutical Industries (Julphar) officially opened a new pharmaceuticals manufacturing facility in February 2013. The new plant is located at Gerji Jakros region in Ethiopian capital city Addis Ababa. It was developed by Julphar in association with Medtech, a local Ethiopian company.
The inauguration ceremony of the new manufacturing plant was attended by Hailemariam Desalegn, the Prime Minister of Ethiopia.
The plant is expected to become fully operational in the second quarter of 2013. The investment for the construction of the plant was about ETB170m ($9.17m). Details of Julphar’s pharmaceutical facility in Ethiopia
The new facility has a total floor space of about 40,000ft2. It will produce solid as well as liquid dosage forms of medicines. It will manufacture about 25 million bottles of suspension and syrup, 500 million tablets, and more than 200 million capsules.
It will provide many employment opportunities and is expected to recruit 50 local staff for various positions such as quality assurance, quality control, production and maintenance, regulatory affairs, and administration services.
The new plant was built in order to produce relevant and much needed medicines for Ethiopian market. The pharmaceutical products produced at the new facility will be exported throughout Africa. Medtech manages the sales and marketing of the products and will become a key supplier in the local as well as other markets in the African continent.